DeepSeek on April 29 began limited testing of a vision mode, with some users gaining access on both its web version and app after updating. The new option appears alongside the existing Fast Mode and ...

PHOENIX — A new pancreatic cancer drug being tested by doctors in Phoenix is showing promise, potentially doubling survival rates for patients compared to chemotherapy alone. Pancreatic cancer is one ...

Preoperative topical anesthesia appears to be associated with significantly lower rate of postoperative diplopia than retrobulbar injection. Diplopia onset is rare following cataract surgery, but use ...

JEC Composites Magazine: You developed the Double-Double concept more than a decade ago. Can you remind us how Double-Double is defined? Stephen Tsai: The traditional ply schedule, called the Quad, ...

Every Wednesday and Friday, TechNode’s Briefing newsletter delivers a roundup of the most important news in China tech, straight to your inbox. Sign up In China’s domestic large model sector, DeepSeek ...

The Centers for Disease Control and Prevention (CDC) has paused its diagnostic testing for a host of infectious diseases, including rabies. The CDC on Monday posted a list of 27 tests that it either ...

Matt Elliott is a senior editor at CNET with a focus on laptops and streaming services. Matt has more than 20 years of experience testing and reviewing laptops. He has worked for CNET in New York and ...

An apparent large-scale operation Friday night tied to the disappearance of 84-year-old Nancy Guthrie marks a “significant escalation” in the Arizona case, with investigators now racing to canvas ...

OSAT leader ASE Technology Holding is optimistic that its growth momentum will extend through 2026 and beyond, benefiting from the short supply of advanced packaging and testing capacity. COO Tien Wu ...

As the calendar has turned to February, the arrival of the 2026 NTT INDYCAR SERIES season is getting real as teams prepare for two major preseason tests in the next two weeks. Ten teams are heading to ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...